Market Value660,558,000
Total Holdings65
File Date2021-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VRDN / Viridian Therapeutics, Inc.
MRK / Merck & Co., Inc.
LNTH / Lantheus Holdings, Inc.
NVRO / Nevro Corp.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
RFL / Rafael Holdings, Inc.
MDNA / Medicenna Therapeutics Corp
FATE / Fate Therapeutics, Inc.
US462222AB68 / Ionis Pharmaceuticals Inc
MSON / Misonix Inc
ZYME / Zymeworks Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
IRMD / IRADIMED CORPORATION
PAYX / Paychex, Inc.
DRIO / DarioHealth Corp.
CRSP / CRISPR Therapeutics AG
DXCM / DexCom, Inc.
OSH / Oak Street Health Inc
KYMR / Kymera Therapeutics, Inc.
TPTX / Turning Point Therapeutics Inc
MRSN / Mersana Therapeutics, Inc.
US92538T1043 / VESPER HEALTHCARE ACQUISITION CORP A
TARA / Protara Therapeutics, Inc.
TRIL / Trillium Therapeutics Inc
HZNP / Horizon Therapeutics Plc
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
ISEE / IVERIC bio Inc
BHVN / Biohaven Ltd.
RVNC / Revance Therapeutics, Inc.
KDMN / Kadmon Holdings Inc
PRVB / Provention Bio Inc
LYRA / Lyra Therapeutics, Inc.
CRDF / Cardiff Oncology, Inc.
BIIB / Biogen Inc.
PIRS / Pieris Pharmaceuticals, Inc.
HIMS / Hims & Hers Health, Inc.
US38341PAA03 / Gossamer Bio Inc
AFMD / Affimed N.V.
US0153511094 / Alexion Pharmaceuticals, Inc.
VCEL / Vericel Corporation
ABBV / AbbVie Inc.
GLTO / Galecto, Inc.
SBTX / Silverback Therapeutics Inc
NVTA / Invitae Corporation
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
CCCC / C4 Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
MRTX / Mirati Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
EXEL / Exelixis, Inc.
STAA / STAAR Surgical Company
ADVM / Adverum Biotechnologies, Inc.
NEO / NeoGenomics, Inc.
HIMS / Hims & Hers Health, Inc.
IRTC / iRhythm Technologies, Inc.
ONCR / Oncorus, Inc.
TCRR / Tcr2 Therapeutics Inc
COGT / Cogent Biosciences, Inc.
XENE / Xenon Pharmaceuticals Inc.
INBX / Inhibrx Biosciences, Inc.
BCAB / BioAtla, Inc.
NTRA / Natera, Inc.
EPIX / ESSA Pharma Inc.
AXGN / Axogen, Inc.
NVCR / NovoCure Limited
KRYS / Krystal Biotech, Inc.
SRDX / Surmodics, Inc.
ESTA / Establishment Labs Holdings Inc.